Bioventus Financial Statements From 2010 to 2026

Stocks USA . 
Stock . Bioventus
BVS Stock  USD 7.95  0.34  4.47%   
Bioventus' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bioventus' valuation are provided below:
Gross Profit
382 M
Profit Margin
0.018
Market Capitalization
509.7 M
Enterprise Value Revenue
1.4013
Revenue
563.8 M
There are over one hundred nineteen available fundamental signals for Bioventus, which can be analyzed over time and compared to other ratios. All traders should validate Bioventus' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 1.1 B in 2026, whereas Market Cap is likely to drop slightly above 360.7 M in 2026.

Bioventus Total Revenue

394.59 Million

Check Bioventus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioventus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 40.1 M, Interest Expense of 46.8 M or Total Revenue of 394.6 M, as well as many indicators such as Price To Sales Ratio of 1.31, Dividend Yield of 5.0E-4 or PTB Ratio of 4.93. Bioventus financial statements analysis is a perfect complement when working with Bioventus Valuation or Volatility modules.
  
Build AI portfolio with Bioventus Stock
Check out the analysis of Bioventus Correlation against competitors.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Bioventus Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding61.1 M75.2 M57.1 M
Slightly volatile
Total Assets790.1 M837.1 M629.4 M
Slightly volatile
Short and Long Term Debt Total300 M386 M247.9 M
Slightly volatile
Other Current Liabilities115.1 M178.8 M87.4 M
Slightly volatile
Total Current Liabilities157.4 M242 M119.2 M
Slightly volatile
Total Stockholder Equity233 M170.1 M194.7 M
Pretty Stable
Property Plant And Equipment Net28.6 M38.5 M20.7 M
Slightly volatile
Net Debt255.1 M338.2 M212.1 M
Slightly volatile
Accounts Payable16.3 M27.2 M12.6 M
Slightly volatile
Cash44.9 M47.8 M35.8 M
Slightly volatile
Non Current Assets Total568 M520.2 M450.9 M
Slightly volatile
Non Currrent Assets Other2.1 M2.2 M29.3 M
Pretty Stable
Cash And Short Term Investments44.9 M47.8 M35.8 M
Slightly volatile
Net Receivables105 M146.5 M85 M
Slightly volatile
Good Will6.4 M6.7 M43.6 M
Slightly volatile
Common Stock Total Equity64.1 K67.5 K123.9 M
Slightly volatile
Liabilities And Stockholders Equity790.1 M837.1 M629.4 M
Slightly volatile
Non Current Liabilities Total369 M381.7 M296.3 M
Slightly volatile
Inventory58.2 M106.3 M47.2 M
Slightly volatile
Other Current Assets14 M16.3 M10.4 M
Slightly volatile
Total Liabilities526.4 M623.7 M415.5 M
Slightly volatile
Property Plant And Equipment Gross101.1 M96.3 M33.8 M
Slightly volatile
Total Current Assets222.1 M317 M178.5 M
Slightly volatile
Short Term Debt22.3 M31.4 M16.3 M
Slightly volatile
Intangible Assets423 M465.4 M348.3 M
Slightly volatile
Common Stock70.1 K73.8 K123.9 M
Slightly volatile
Other Liabilities207.2 M197.3 M93.2 M
Slightly volatile
Other Assets31.3 M58.1 M27.4 M
Slightly volatile
Property Plant Equipment17.4 M26.4 M14.7 M
Slightly volatile
Long Term Debt306.6 M354.5 M242.9 M
Slightly volatile
Net Invested Capital568.1 M556.1 M438.8 M
Slightly volatile
Long Term Investments2.9 M3 M5.3 M
Pretty Stable
Short and Long Term Debt21.5 M31.4 M13.6 M
Slightly volatile
Capital Stock70.1 K73.8 K184.5 M
Slightly volatile
Non Current Liabilities Other41.7 M26.6 M22.2 M
Slightly volatile
Short Term Investments15.5 M17.4 M19 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity59.9 M67.4 M73.5 M
Slightly volatile
Capital Surpluse372.2 M418.7 M457.1 M
Slightly volatile
Deferred Long Term Liabilities106.8 M120.2 M131.2 M
Slightly volatile

Bioventus Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization40.1 M57 M35.8 M
Slightly volatile
Interest Expense46.8 M44.6 M20.1 M
Slightly volatile
Total Revenue394.6 M659.3 M356.2 M
Slightly volatile
Gross Profit271.3 M446.5 M244.7 M
Slightly volatile
Other Operating Expenses406.4 M673 M366.7 M
Slightly volatile
Research Development13.9 M15.7 M12.6 M
Slightly volatile
Cost Of Revenue123.3 M212.8 M111.5 M
Slightly volatile
Total Operating Expenses283.1 M460.2 M255.2 M
Slightly volatile
Selling General Administrative279.4 M371.1 M233.1 M
Slightly volatile
Reconciled Depreciation49.1 M57 M38.4 M
Slightly volatile
Selling And Marketing Expenses4.1 M5.1 M3.1 M
Slightly volatile
Non Recurring6.5 M7.3 M8 M
Slightly volatile

Bioventus Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow52.5 M42.5 M43.1 M
Slightly volatile
Depreciation40.9 M57 M35.4 M
Slightly volatile
Dividends Paid6.4 M3.9 M5.1 M
Pretty Stable
Capital Expenditures860.1 K905.4 K7.1 M
Slightly volatile
End Period Cash Flow51.1 M47.8 M45.3 M
Slightly volatile
Change To Netincome18.1 M10.7 M22.9 M
Slightly volatile
Change To Liabilities13.8 M20.9 M11.9 M
Slightly volatile
Cash And Cash Equivalents Changes10.1 M11.3 M12.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.311.382.9399
Slightly volatile
Dividend Yield5.0E-45.0E-40.0043
Very volatile
PTB Ratio4.935.335.2739
Slightly volatile
Days Sales Outstanding70.7573.081.7493
Slightly volatile
Book Value Per Share3.592.563.7906
Pretty Stable
Stock Based Compensation To Revenue0.03290.02020.0367
Slightly volatile
Capex To Depreciation0.02220.02330.2603
Slightly volatile
PB Ratio4.935.335.2739
Slightly volatile
EV To Sales3.231.973.506
Slightly volatile
Inventory Turnover2.762.32.6438
Slightly volatile
Days Of Inventory On Hand121164142
Slightly volatile
Payables Turnover11.648.9811.284
Slightly volatile
Sales General And Administrative To Revenue0.650.56280.5959
Slightly volatile
Research And Ddevelopement To Revenue0.03980.02740.0378
Slightly volatile
Capex To Revenue0.00190.0020.026
Slightly volatile
Cash Per Share0.650.570.6534
Slightly volatile
Days Payables Outstanding32.1642.0536.0318
Slightly volatile
Intangibles To Total Assets0.680.650.6587
Slightly volatile
Current Ratio1.741.511.7228
Slightly volatile
Receivables Turnover4.615.184.5214
Slightly volatile
Shareholders Equity Per Share3.192.043.4721
Very volatile
Debt To Equity1.122.041.314
Slightly volatile
Capex Per Share0.01680.01770.1548
Pretty Stable
Revenue Per Share5.27.896.0933
Slightly volatile
Interest Debt Per Share4.225.164.5651
Slightly volatile
Debt To Assets0.320.410.3991
Pretty Stable
Graham Number4.948.855.02
Slightly volatile
Operating Cycle192237223
Slightly volatile
Price Book Value Ratio4.935.335.2739
Slightly volatile
Days Of Payables Outstanding32.1642.0536.0318
Slightly volatile
Company Equity Multiplier2.784.433.1927
Slightly volatile
Long Term Debt To Capitalization0.440.610.531
Slightly volatile
Total Debt To Capitalization0.460.620.5469
Slightly volatile
Debt Equity Ratio1.122.041.314
Slightly volatile
Quick Ratio1.311.01.2946
Slightly volatile
Cash Ratio0.40.230.3732
Very volatile
Cash Conversion Cycle160195187
Slightly volatile
Days Of Inventory Outstanding121164142
Slightly volatile
Days Of Sales Outstanding70.7573.081.7493
Slightly volatile
Price To Book Ratio4.935.335.2739
Slightly volatile
Fixed Asset Turnover24.2419.6727.6236
Pretty Stable
Debt Ratio0.320.410.3991
Pretty Stable
Price Sales Ratio1.311.382.9399
Slightly volatile
Asset Turnover0.470.710.5999
Very volatile
Gross Profit Margin0.760.780.7015
Pretty Stable
Price Fair Value4.935.335.2739
Slightly volatile

Bioventus Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap360.7 M379.7 M807.2 M
Slightly volatile
Enterprise Value1.1 B791.2 M1.1 B
Slightly volatile

Bioventus Fundamental Market Drivers

Forward Price Earnings9.2764
Cash And Short Term Investments41.6 M

Bioventus Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
21st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bioventus Financial Statements

Bioventus shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Bioventus investors may analyze each financial statement separately, they are all interrelated. The changes in Bioventus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bioventus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue5.5 M5.2 M
Total Revenue659.3 M394.6 M
Cost Of Revenue212.8 M123.3 M
Stock Based Compensation To Revenue 0.02  0.03 
Sales General And Administrative To Revenue 0.56  0.65 
Research And Ddevelopement To Revenue 0.03  0.04 
Revenue Per Share 7.89  5.20 
Ebit Per Revenue(0.02)(0.03)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY